You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pet Scan

Showing 26 - 50 of 9,123
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

A Study of Metabolic Agents Following Brain Radiation

Enrolling by invitation
  • CNS Malignancy
  • F-DOPA Positron Emission Tomography
  • Chemical Exchange Saturation Transfer Magnetic Resonance Imaging
  • Rochester, Minnesota
    Mayo Clinic
Nov 21, 2023

Meningioma Trial in Houston (Computed Tomography, Gallium Ga 68-DOTATATE, Positron Emission Tomography)

Recruiting
  • Meningioma
  • Computed Tomography
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 28, 2022

Lung Non-Small Cell Carcinoma, Malignant Solid Tumor, Melanoma Trial in Duarte (procedure, other, radiation)

Not yet recruiting
  • Lung Non-Small Cell Carcinoma
  • +3 more
  • Biospecimen Collection
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Apr 13, 2023

Breast Carcinoma, Calcification Trial in Duarte (procedure, drug, other)

Recruiting
  • Breast Carcinoma
  • Calcification
  • Computed Tomography
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Dec 13, 2022

Pancreatic Adenocarcinoma Trial in Dallas (drug, procedure, other)

Completed
Has Results
  • Pancreatic Adenocarcinoma
  • 3'-deoxy-3'-[F-18] fluorothymidine: [F-18]FLT
  • +3 more
  • Dallas, Texas
    UT Southwestern Medical Center
Oct 10, 2022

Brain Metastases Trial in Houston (18F-Fluciclovine (Axumin), Pet Scan)

Not yet recruiting
  • Brain Metastases
  • 18F-Fluciclovine (Axumin)
  • Pet Scan
  • Houston, Texas
    M D Anderson Cancer Center
Aug 23, 2023

Giant Cell Arteritis Trial in Dijon (drug, other, biological, procedure)

Not yet recruiting
  • Giant Cell Arteritis
  • Tocilizumab treatment
  • +3 more
  • Dijon, France
    Chu Dijon Bourgogne
Sep 7, 2023

Breast Carcinoma Trial in Houston (Computed Tomography, Fluorine F 18 Fluorthanatrace, Positron Emission Tomography)

Recruiting
  • Breast Carcinoma
  • Computed Tomography
  • +2 more
  • Philadelphia, Pennsylvania
  • +1 more
Dec 14, 2022

Squamous Cell Carcinoma of the Head and Neck Trial in Stanford ([18F]F-AraG PET Scan, baseline + post anti-PD-1 therapy.)

Completed
  • Squamous Cell Carcinoma of the Head and Neck
  • [18F]F-AraG PET Scan, baseline + post anti-PD-1 therapy.
  • Stanford, California
    Stanford Hospital and Clinics
Dec 1, 2022

Lung Adenocarcinoma Trial in Los Angeles (drug, procedure, other)

Recruiting
  • Lung Adenocarcinoma
  • Los Angeles, California
    Yesenia Calzada
Jan 27, 2023

Breast Carcinoma, Fallopian Tube Carcinoma, Ovarian Carcinoma Trial in Houston (Computed Tomography, Fludeoxyglucose F-18,

Recruiting
  • Breast Carcinoma
  • +7 more
  • Computed Tomography
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 24, 2022

Tauopathies Trial in Philadelphia (drug, diagnostic test, behavioral)

Active, not recruiting
  • Tauopathies
  • 11C-HY-2-15 PET
  • +3 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Sep 6, 2023

Parkinson Disease Trial in Toulouse (Clinical assessment, Pain characteristics assessment, MRI)

Not yet recruiting
  • Parkinson Disease
  • Clinical assessment
  • +5 more
  • Toulouse, Haute-Garonne, France
    Centre Hospitalier Universitaire de Toulouse
Aug 22, 2023

Cardiovascular Diseases Trial (PET scan)

Not yet recruiting
  • Cardiovascular Diseases
  • PET scan
  • (no location specified)
Jan 23, 2023

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in San Francisco

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +4 more
  • Computed Tomography
  • +3 more
  • San Francisco, California
    University of California San Francisco
Dec 19, 2022

Sex and Obesity: Effects on Heart Failure Study

Active, not recruiting
  • Obesity
  • Heart Failure
  • PET (positron Emission Tomography)
  • +7 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 30, 2023

Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8, Stage IIA Prostate Cancer AJCC v8 Trial in Chicago (procedure,

Not yet recruiting
  • Prostate Adenocarcinoma
  • +3 more
  • Biopsy of Prostate
  • +6 more
  • Chicago, Illinois
    Northwestern University
May 9, 2023

Prostate Adenocarcinoma Trial in Tucson (F-18 fluciclovine-PET/CT scan)

Completed
Has Results
  • Prostate Adenocarcinoma
  • F-18 fluciclovine-PET/CT scan
  • Tucson, Arizona
    University of Arizona
Aug 12, 2022

Neuroimaging Studies of Reward Processing in Depression

Completed
  • Major Depressive Disorder
  • PET Scan with Raclopride
  • Belmont, Massachusetts
    David Crowley
Feb 1, 2023

PSMA-PET Imaging of Salivary Gland Tumours and Other Rare

Recruiting
  • Salivary Gland Tumor
  • Rare Malignant Neoplasm
  • 68-Ga PSMA PET scan
  • Singapore, Singapore
    National Cancer Centre Singapore
Oct 11, 2022

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, HER2-Positive Breast Carcinoma Trial (drug,

Not yet recruiting
  • Anatomic Stage II Breast Cancer AJCC v8
  • +3 more
  • (no location specified)
Jan 24, 2023

Sickle Cell Disease Trial (Positron Emission Tomography, Cu-64]-LLP2A)

Recruiting
  • Sickle Cell Disease
  • Pittsburgh, Pennsylvania
    UPMC
Dec 2, 2022

Prostate Tumor Trial in Los Angeles (device, drug, other, procedure)

Active, not recruiting
  • Prostate Neoplasm
  • CAT
  • +5 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Aug 19, 2022

Prostate Cancer Trial in Edmonton (PSMA-1007 Positron Emission Tomography (PET) scan and 3T Magnetic Resonance Imaging (MRI))

Recruiting
  • Prostate Cancer
  • PSMA-1007 Positron Emission Tomography (PET) scan and 3T Magnetic Resonance Imaging (MRI)
  • Edmonton, Alberta, Canada
    University of Alberta
Jan 9, 2023

Lung Carcinoma, Solitary Pulmonary Nodule, Cigarette Smoking Behavior Trial in Nashville (procedure, radiation, drug, other)

Completed
Has Results
  • Lung Carcinoma
  • +2 more
  • Computed Tomography
  • +5 more
  • Nashville, Tennessee
  • +1 more
Oct 17, 2022